SMARCA4 Loss in Lung Cancer Is Associated with Distinct Clinicopathologic Features
Publication
, Conference
Glass, CH; Redig, AJ; Hung, YP; French, C; Sholl, LM
Published in: LABORATORY INVESTIGATION
2017
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2017
Volume
97
Start / End Page
479A / 479A
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Glass, C. H., Redig, A. J., Hung, Y. P., French, C., & Sholl, L. M. (2017). SMARCA4 Loss in Lung Cancer Is Associated with Distinct Clinicopathologic Features. In LABORATORY INVESTIGATION (Vol. 97, pp. 479A-479A).
Glass, Carolyn H., Amanda J. Redig, Yin P. Hung, Christopher French, and Lynette M. Sholl. “SMARCA4 Loss in Lung Cancer Is Associated with Distinct Clinicopathologic Features.” In LABORATORY INVESTIGATION, 97:479A-479A, 2017.
Glass CH, Redig AJ, Hung YP, French C, Sholl LM. SMARCA4 Loss in Lung Cancer Is Associated with Distinct Clinicopathologic Features. In: LABORATORY INVESTIGATION. 2017. p. 479A-479A.
Glass, Carolyn H., et al. “SMARCA4 Loss in Lung Cancer Is Associated with Distinct Clinicopathologic Features.” LABORATORY INVESTIGATION, vol. 97, 2017, pp. 479A-479A.
Glass CH, Redig AJ, Hung YP, French C, Sholl LM. SMARCA4 Loss in Lung Cancer Is Associated with Distinct Clinicopathologic Features. LABORATORY INVESTIGATION. 2017. p. 479A-479A.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2017
Volume
97
Start / End Page
479A / 479A
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences